Thus, we speculate the loss of TJ protein during HCC progression on the background of inflammation [20, 24], consequently released in the circulation, perhaps increased plasma ZO-1 in observed in HCC patients. This evidence concerns the gene TJP1 and hepatocellular carcinoma.